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Abstract
Background: Interactions of glycoconjugates with endogenous galectins, have been long proposed to participate in several
reproductive processes including implantation. In human placenta gal-1, gal-3, gal-8, and gal-13 proteins are known to be
present. Each of them has been proposed to play multiple functions, but so far no clear picture has emerged. We
hypothesized that gal-1 participates in trophoblast invasion, and conducted Matrigel invasion assay using isolated
cytotrophoblast from first trimester placenta and HTR-8/SVneo cell line to test it.
Methods and Findings: Function blocking anti-gal-1 antibody was employed to assess participation of endogenous gal-1 in
cell adhesion, cell invasion of HTR-8/SVneo cells. When gal-1 was blocked in isolated trophoblast cell invasion was reduced
to 75% of control (SEM66.3, P,0.001) and to 66% of control (SEM61.7, P,0.001) in HTR-8/SVneo cell line. Increased
availability of gal-1, as two molecular forms of recombinant human gal-1 (CS-gal-1 and Ox-gal-1), resulted in increased cell
invasion by cytotrophoblast to 151% (SEM616, P,0.01) with 1 ng/ml of CS-gal-1, and to 192% (SEM651, P,0.05) with
1 mg/ml of Ox-gal-1. Stimulation was also observed in HTR-8/SVneo cells, to 317% (SEM658, P,0.001) by CS-gal-1, and to
200% (SEM624, P,0.001) by Ox-gal-1 at 1 mg/ml. Both sets of results confirmed involvement of gal-1 in trophoblast
invasion. Galectin profile of isolated cytotrophoblast and HTR-8/SVneo cells was established using RT-PCR and real-time PCR
and found to consist of gal-1, gal-3 and gal-8 for both cell types. Only gal-1 was located at the trophoblast cell membrane,
as determined by FACS analysis, which is consistent with the results of the functional tests.
Conclusion and Significance: These findings qualify gal-1 as a member of human trophoblast cell invasion machinery.
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Introduction
Essential steps in achieving a successful pregnancy include
development of an implantation competent blastocyst, subsequent
implantation into an adequately prepared endometrium and
formation of a functional placenta. During early embryo
implantation and development of the human placenta, specialized
trophoblast cells orchestrate a complex series of stage-specific
adhesive interactions with multiple components. This has been
shown in particular for invasive cytotrophoblast cells, which form
the anchoring villi, attaching the conceptus to maternal decidua.
As they differentiate, the invasive trophoblast cells undergo a well
documented integrin switch [1] that enables invasion as well as cell
adhesion in maternal interstitial and endovascular compartments
[2]. The invasive trophoblast cells acquire a full repertoire of
adhesion and other molecules that allow them to detach from the
cell columns of the anchoring villi and invade maternal decidua.
Accumulated data have shown that interactions of cell receptors
with the extracellular matrix (ECM) are of particular importance
for this process. The extravillous cytotrophoblast at the fetoma-
ternal interface has been shown to produce a specific extracellular
matrix that includes heavily glycosylated ECM proteins such as
laminin [3] and oncofetal fibronectin [4].
Galectin-1 (gal-1) belongs to the phylogenetically conserved
galectin family with an affinity for Gal-GlcNAc residues of
glycoproteins. It exists as a noncovalent homodimer composed
of two carbohydrate recognition domains which recognize a wide
range of glycoconjugates [5,6]. Although gal-1 has characteristics
of a typical cytoplasmic protein, it can be secreted and found on
the cell surface, as well as in the extracellular matrix [7,8]. It could
therefore act both inside cells, via sugar-independent interactions
[9], and outside cells displaying lectin activity [10,11]. Through
recognition and interactions with b-galactoside containing
ligands/counter receptors on the cell surface or in the ECM, this
lectin plays a role in a variety of biological functions, including cell
adhesion, migration, invasion, metastasis, apoptosis, and assembly
and remodeling of ECM [7,12]. It has been documented that gal-1
binds to various ECM components - laminin, cellular fibronectin,
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galactoside-dependent manner [13–15].
The presence of gal-1 has been shown in human, as well as in
mouse female reproductive tracts. This protein was the first
galectin isolated, purified and cloned from human placenta [16]. It
is expressed at the maternofetal interface [17]. Among placental
trophoblast cells, gal-1 was immunolocalized in the cytotropho-
blast of middle and distal cell columns [18] differentiating towards
fully invasive trophoblast. Gal-1 is also abundantly expressed in
endometrium, as well as in the decidua of early gestation [19,20].
Other members of the galectin family, gal-3, gal-8, and gal-13,
were also reported in human placenta [18,21–23]. In mice [24,25]
gal-1 is synthesized prior to implantation in the trophectoderm of
the expanded blastocysts, suggesting a role in the attachment of
the embryo to the uterine epithelium [24]. Although studies of gal-
1 and gal-3 double knockouts demonstrate no effect on
reproductive phenotype, and that both molecules are dispensable
for survival and fertilization, some subtle defects have been found.
Therefore, it has been proposed that gal-1 and gal-3 may be
molecules required for the most efficient, but not for absolute
function [26], or that gal-5, also expressed by mouse blastocyst,
could be involved as well [27]. However, a recent study reported
that gal-1 deficient mice have higher rates of fetal loss compared to
wild type mice [28], which is preventable by treatment with
recombinant gal-1, suggesting its important role in the mainte-
nance of pregnancy.
It is widely accepted that implantation of the human embryo is a
process that depends on invasive properties of the trophoblast, for
which both glycocode and glycan-binding proteins may play
important roles [29–31]. Galectins bind and cross-link N-glycans
on cell surface glycoproteins to form a heterogeneous lattice [32].
Gal-1 has been implicated in some of the pathological conditions
involving trophoblast, such as early pregnancy loss, preeclampsia
and trophoblastic malignant disease [33–35]. It was previously
demonstrated that lactose, an inhibitory sugar for the lectin-type
interaction of galectins, reduced invasion by extravillous tropho-
blast HTR-8/SVneo cell line [36]. In tumor biology gal-1 was
shown to influence cell invasiveness [37,38]. No direct data,
however, are yet available regarding its involvement in trophoblast
invasion. This study established the galectin profile of invasive
trophoblast and for the first time investigated gal-1 involvement in
the processes relevant for human embryo implantation, such as
cell invasion, using functional tests in vitro.
Materials and Methods
Reagents and antibodies
RPMI 1640 with or without phenol red, DMEM/F12 medium,
antibiotic/antimycotic solution and fetal calf serum (FCS) were
obtained from PAA Laboratories (Linz, Austria). Matrigel,
collagen type I and fibronectin were purchased from BD
Biosciences (Bedford, MA, USA). Propidium iodide (PI), Trypan
blue, acrylamide, N, N9-methylene-bis-acrylamide, N, N, N9,N 9-
tetramethylenediamine, Ponceau S, glycine, protease inhibitor
cocktail, and MTT were obtained from Sigma Chemical
Company (USA). SDS-PAGE protein standards were from Bio-
Rad. The oxidized form of recombinant human gal-1 (Ox-gal-1)
and a mutant form of gal-1 in which all six cysteine residues were
replaced by serine (CS-gal-1) were obtained from Kirin Brewery
(Japan). The following antibodies were used: rabbit anti-gal-1 with
gal-1 neutralizing activity (Kirin Brewery, Japan), rabbit anti-b-
actin (Sigma), mouse anti-cytokeratin-7 (CK-7, Dako, Glostrup,
Denmark), rabbit anti-Ki-67 (SantaCruz Biotechniology Inc,
USA), goat anti-gal-8 (R&D, Abingdon, UK) and mouse anti-
gal-3 (gift from Dr M Huflejt). Non-immune rabbit IgG, non-
immune mouse IgG, biotinylated horse anti-mouse, goat anti-
rabbit and rabbit anti-goat IgG, avidin-biotinylated peroxidase
complex (ABC) and diaminobenzidine (DAB) substrate kit for
peroxidase were obtained from Vector Laboratories (Burlingame,
CA, USA). Anti-mouse IgG antibody Alexa Fluor 488, anti-rabbit
IgG antibody Alexa Fluor 555, anti-goat antibody IgG Alexa Fluor
488 and Prolong Gold antifade reagent with DAPI were from
Molecular Probes (Invitrogen,.USA). Tris and 2-mercaptoethanol
were from ICN Biomedicals, Inc. (Aurora, OH, USA). Protran
nitrocellulose transfer membrane was obtained from Schlei-
cher&Schuell BioScience GmbH Whatman Group (Dassel,
Germany). TRIreagent, primers, dNTPs, AmpliTaq Gold DNA
polymerase were from Applied Biosystems (Carlsbad, USA).
Hexamer primers, RevertAid reverse transcriptase were obtained
from Fermentas (Lithuania) and KAPA
TMSYBRHFAST qPCR
Universal Master Mix was from Kappa Biosystems (Boston, USA).
All other reagents were of the best commercial grade available.
Antibody dilutions for immunocytochemistry were 1:75 for anti-
CK7, 1:100 for anti-gal-1, 1:50 for Ki-67, 1:200 for biotinylated
horse anti-mouse and goat anti-rabbit IgG, and 1:1000 for Alexa
Fluor 488 anti-mouse IgG antibody and Alexa Fluor 555 anti-
rabbit IgG antibody. For Western blot analysis dilutions were
1:2500 for anti-gal-1, 1:10 for anti-gal-3, 1:500 for anti-gal-8 for
primary cytotrophoblast (CT) and HTR-8/SVneo cells, 1:500 for
anti-actin (HTR-8/SVneo cells) and 1:1000 for primary CT.
Biotinylated horse anti-mouse IgG was diluted 1:750 for HTR-8/
SVneo cells and 1:1000 for isolated trophoblast cells, goat anti-
rabbit IgG was diluted 1:1200 for both cell types and rabbit anti-
goat was diluted 1:600 (HTR-8/SVneo) and 1:800 for primary
CT in Western blot analysis.
Isolation of CT and cell culture
HTR-8/SVneo cells were kindly provided by Dr Charles H
Graham (Queen’s University, Kingston, Ontario, Canada). This
cell line was established from human first trimester explant
cultures immortalized by SV40 large T antigen [39,40].
Cytotrophoblast cells were isolated from the first trimester of
pregnancy placentas from legal abortions (6–12 weeks) undertaken
for non-medical reasons. Placental tissues were obtained from
subjects undergoing voluntary termination of pregnancy at Clinic
for Obstetrics and Gynecology, Clinical Center of Serbia,
Belgrade, or Military Medical Academy, Belgrade, after a verbal
consent was given. This was in keeping with the agreements
between each of these institutions and INEP, and according to
local ethical standards (document GSP/05; PR030/09) approved
by Institutional committee of Institute for the Application of
Nuclear Energy, INEP.
The isolation protocol using sequential trypsin digestion has
been reported previously [41,42]. After isolation, cells were
identified as trophoblast by immunocytochemical staining for
CK-7, and preparations with .90% cytokeratin positive cell were
used for all experiments. Since cell preparations also contained a
small proportion of CD45-positive cells (,6%), these cells were
removed using immunomagnetic beads prior to Western blot,
FACS analysis, and RNA isolation, as described below.
Cytotrophoblast was cultured in DMEM/F12 supplemented
with 10% FCS (v/v), and HTR-8/SVneo cells in RPMI 1640
supplemented with 5%FCS (v/v), and with antibiotic/antimycotic
solution. For SDS-PAGE, isolated CT cells or trypsinized HTR-
8/SVneo cells were washed in 0.05 M phosphate buffered saline
(PBS), pH 7.2, lysed in sample buffer containing protease inhibitor
cocktail (6610
6 cells/ml), centrifuged (1600 g for 5 min at 4uC)
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boiling water bath and subjected to SDS-PAGE.
For immunocytochemical analysis CT and HTR-8/SVneo cells
were cultured on glass cover slips in their respective media at 37uC
in a moist atmosphere of air with 5% CO2. Isolated CT was
cultured for 18–20 h. Subconfluent HTR-8/SVneo cells were also
cultured with non-immune rabbit IgG or anti-gal-1 (1 mg/ml) for
24 h at 37uC. Cover slips were then rinsed twice with PBS and
fixed with ice-cold acetone-methanol (1:1) for 10 min. Cover slips
were kept frozen until stained.
For PI and Ki-67 staining, and MTT test, HTR-8/SVneo cells
were cultured in 96-well plates at 1610
5, for FACS analysis, and
2610
4 cells/well for MTT, in 100 ml of complete RPMI 1640.
After 24 h, HTR-8/SVneo cells were briefly rinsed with sterile
PBS (sPBS) and further cultured in control or one of the treatment
media containing: a) anti-gal-1 (1 and 5 mg/ml), b) non-immune
rabbit IgG (1 and 5 mg/ml), c) CS-gal-1 (1 ng/ml, 0.1 and 1 mg/
ml), d) Ox-gal-1 (1 ng/ml, 0.1 and 1 mg/ml), dissolved in RPMI
1640 without phenol red containing 0.1% bovine serum albumin
(BSA), to a total culture volume of 200 ml. After 24 h, the cells
were rinsed twice with warm sPBS.
For RNA isolation, total RNA was collected from subconfluent
cultures of HTR-8/SVneo and isolated cytotrophoblast cells using
TRIreagent according to the manufacturer’s instructions.
Immunocytochemistry
Cytotrophoblast from primary culture and HTR-8/SVneo cells
on coverslips were washed with PBS, air-dried and fixed with ice-
cold acetone-methanol. Endogenous peroxidase activity was
blocked with 1% hydrogen peroxide for 30 min, and non-specific
binding of proteins with 1% casein in PBS for 20 min at room
temperature (RT). Cells were then incubated with anti-CK-7
antibody for 1 h at RT, followed by incubation with biotinylated
horse anti-mouse IgG for 30 min and with ABC for another
30 min. The reaction was visualized using DAB as chromogen. In
double immunostaining experiments, cytokeratin stained tropho-
blast cells were subsequently incubated with anti-gal-1 antibody
overnight and visualized using anti-rabbit IgG Alexa Fluor 555
antibody. Slides were mounted with Prolong Gold antifade
reagent with DAPI and examined using a Carl Zeiss Axio Imager
1.0 microscope with AxioCam HR monochrome camera (Jena,
Germany), or with a Canon A640 Digital Camera System (Tokyo,
Japan).
Negative controls were performed routinely. Omission of
primary antibody and use of non-immune serum in place of
specific antibody resulted in complete absence of staining. HTR-
8/SVneo cells cultured with non-immune rabbit IgG or anti-gal-1
were incubated with secondary anti-rabbit IgG Alexa Fluor 555
antibody only.
Immunohistochemistry
Immunohistochemistry was performed on paraffin-embedded
placental tissue from first trimester of pregnancy. Endogenous
peroxidase activity was quenched by 30 min incubation in 1% (v/
v) H2O2/ethanol followed by a wash with distilled water.
Nonspecific binding was blocked by 20 min incubation with 1%
casein. Sections were incubated with anti-gal-1, overnight at 4uC,
and stained with anti-rabbit IgG Alexa Fluor 555 antibody. For
the negative control primary antibody was omitted.
Cell adhesion
Adhesion assays were performed in 96-well plates in wells either
uncoated or precoated with 250 ng/well of fibronectin, Matrigel
or collagen type I for 1 h at 37uC. The plates were treated with
100 ml 3% BSA in PBS for 30 min at 37uC to block non-specific
binding sites, washed with PBS, and used in the adhesion assay.
The HTR-8/SVneo cells were detached with 5 mM EDTA in
PBS and resuspended at a final concentration of 2.5610
5/ml in
0.1% BSA-RPMI 1640 without phenol red. Cells were preincu-
bated with or without 0.1 M lactose, non-immune rabbit IgG or
anti-gal-1 (1 and 5 mg/ml) for 1 h in a humidified atmosphere of
5% CO2 at 37uC with occasional agitation, and plated at 2.5610
4
cells/well. After incubation for 1 or 2 h, the unattached cells were
removed, and the plates were gently rinsed once with PBS, and
fixed with ice-cold acetone/methanol (1:1) for 10 min. The
attached cells were stained by adding 0.05% crystal violet in
25% methanol at 50 ml/well for 5 min. The excess of dye was
removed by immersing the plates in water and drying at RT. The
incorporated dye was dissolved in 0.1 M sodium citrate in 50%
ethanol at 100 ml/well and optical density was read at 540 nm.
The intensity of staining was proportional to the number of
adhered cells. The experiments were repeated three times.
HTR-8/SVneo cell survival in the presence of gal-1
Cell viability was assessed by MTT assay [43]. HTR-8/SVneo
cells were cultured in 96-well plates as described above. After
treatment, 100 ml of MTT (2.4 mmol/l) in 10% FCS/PBS (v/v)
were added to each well. After incubation for 2 h at 37uC, the
medium was replaced by 1-propanol (100 ml/well), and the plates
were vigorously shaken to ensure complete solubilizaiton of the
blue formazan. Absorbance was measured at 570 nm using a
microplate reader and the cells were quantified using the standard
curve obtained with 5610
3,1 610
4,2 610
4,4 610
4,6 610
4,o r
8610
4 cells/well. The experiment was repeated four times for
both concentrations of anti-gal-1 antibodies, non-immune rabbit
IgG and 0.1 M lactose, or three times for Ox-gal-1 and CS-gal-1
(1 ng/ml, 0.1 and 1 mg/ml).
The effect of gal-1 on cell proliferation was investigated by
immunostaining of HTR-8/SVneo cells for Ki-67 nuclear antigen
followed by FACS analysis, as detailed bellow. Presence of
apoptotic HTR-8/SVneo cells was determined by PI staining
after incubation with Ox-gal-1 and CS-gal-1 (1 ng/ml and 1 mg/
ml). For PI, cells were washed with cold PBS and resuspended in
300 ml of hypotonic solution (0.1% sodium citrate and 0.1%
Triton X-100 in distilled water) and PI (40 mg/ml), and kept at
4uC overnight, before quantitation by EPICS XL-MCL flow
cytometer.
Cell invasion assay
The transwell invasion assay was conducted in 24 well plates
with membrane inserts (8 mm pore size; Millipore), as described
previously [44], with minor modifications. Insert membranes were
pre-coated with 10 ml of growth factor-reduced Matrigel at 2 mg/
ml for 30 min at 37uC. Isolated CT (2610
5/200 ml) and HTR-8/
SVneo cells (1610
5/200 ml) were resuspended in one of the
treatment media with 0.1% BSA containing: anti-gal-1 or non-
immune IgG (1 and 5 mg/ml), 0.1 M lactose, CS-gal-1 or Ox-gal-
1 (1 ng/ml and 1 mg/ml for primary CT; 1 mg/ml for HTR-8/
SVneo), 0.1 M lactose with 1 mg/ml CS-gal-1 or Ox-gal-1 (HTR-
8/SVneo). For control, cells were resuspended in medium without
treatment. Cells were then seeded in the upper chamber of
Matrigel-coated transwells. The lower chambers were loaded with
500 ml of medium without or with anti-gal-1 or non-immune IgG,
0.1 M lactose, CS-gal-1 or Ox-gal-1, and 0.1 M lactose and CS-
gal-1 or Ox-gal-1. After incubation for 24 h in a humidified
atmosphere, filters were washed twice in warm PBS, and cells on
the upper surface were gently removed with a cotton swab. Cells
were fixed with ice-cold acetone-methanol (1:1) for 10 min. Filters
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the same procedure as described above, and by Giemsa staining
for HTR-8/SVneo cells. Cells on the underside of the filters and
the pores occupied were counted in non-overlapping fields of the
whole membranes under a light microscope (Reichert-Jung with
Leica DC150 Digital Camera System). The CT cells used were
isolated from nine placentas for treatment with anti-gal-1 and
lactose, from four placentas for CS-gal-1 treatment and from five
placentas for Ox-gal-1 treatment. The experiments were repeated
four times in duplicate for 1 mg/ml of anti-gal-1; eight times in
duplicate for 5 mg/ml of anti-gal-1; three times in duplicate for
each molecular form of gal-1 for HTR-8/SVneo cells. Data
presented for HTR-8/SVneo cells were expressed as a percentage
of the control values. In the Matrigel invasion test, isolated CT
differentiates to non-proliferative trophoblast.
RT-PCR
First-strand cDNA was synthesized from 2 mg of total RNA,
using 0.2 mg of random hexamer primers (Fermentas, Lithuania),
2.5 mM of each dNTP (Applied Biosystems) and 200 U of
RevertAid reverse transcriptase (Fermentas, Lithuania) in a total
volume of 20 ml, according to the manufacturer’s instructions.
Each gene was amplified by PCR reaction in a final volume of
25 ml containing 200 ng of cDNA (2 ml of RT mixture), 2.5 mMo f
each dNTP, 1 mM of each of the primers (sequences previously
published in 45) and 0.25 U of AmpliTaq Gold DNA polymerase.
The temperature profile included initial denaturation at 95uC for
10 min followed by 35 cycles of 1 min at 95uC, 1 min at 60uC,
and 1 min at 72uC, and a final extension step at 72uC for 10 min.
PCR products were analyzed electrophoretically on 2% agarose
gel and visualized by ethidium bromide staining and UV light.
Real-time PCR
Quantitative real-time PCR was performed using the SYBRH
Green chemistry in a 7500 Real Time PCR System (Applied
Biosystems, Carlsberg, USA). The reaction mixture in a final
volume of 10 ml contained 100 ng of cDNA (1 ml of RT mixture),
5 ml2 6KAPA
TMSYBRHFAST qPCR Universal Master Mix and
gene-specific primers [45] in final concentration of 0.4 mM. The
cycling conditions were as follows: denaturation step at 95uC for
10 min followed by 40 cycles of 95uC for 15 s and 60uC for 1 min.
Each sample was amplified in duplicate, followed by melting curve
analyses to verify amplification specificity. All primers exhibited
optimal amplification efficiencies in serial dilution experiments.
GAPDH was used as the endogenous control gene. Calculations
were made using the comparative ddCt method [46].
SDS-PAGE and immunoblotting
SDS-PAGE was performed on 15% polyacrylamide gel and 4%
stacking gel under reducing conditions.Allsamples (HTR-8/SVneo
and CT cell lysates) were prepared by boiling in 0.125 M Tris-HCl
buffer, containing 4% SDS (w/v), 20% glycerol (v/v), 0.1%
bromphenol blue, and 10% 2-mercaptoethanol (v/v) for 5 min,
and 80 mg of protein were loaded per lane. Bio-Rad molecular
weight markers were used according to the manufacturers’
instructions. The proteins separated by electrophoresis were
tranferred onto nitrocellulose membranes. Transfer was performed
at constant voltage (15 V) for 30 min, and was confirmed by
Ponceau S staining of the membranes. Non-specific binding sites on
membranes were blocked with 5% casein in PBS (w/v), at RT for
1 h. After blocking, membranes with immobilized antigens were
incubated with: rabbit anti-gal-1, mouse anti-gal-3 and goat anti-
gal-8 overnight at 4uC, with constant shaking. Subsequent to five
washesfor5 mineach,blottingmembraneswereincubatedwiththe
corresponding biotinylated secondary antibody for 30 min. After
intensive washing, membranes were incubated with ABC for
30 min. Bound conjugates were visualized using DAB/Ni as
chromogen. Non-specific binding was estimated by omitting the
specific antibody. Staining for actin was used as the loading control.
Membranes were scanned and analyzed by the ImageMaster
TotalLab v2.01 program (Amersham Biosciences).
Flow cytometry
Flow cytometry was used to analyse expression of intra- and
extracellular gal-1, gal-3 and gal-8 on HTR-8/SVneo and isolated
trophoblast cells. Magnetic beads coated with antibody to CD45
were employed to deplete bone-marrow derived cells from the
isolated CT cell suspension. Dynabeads – M-280 sheep anti-mouse
IgG (Invitrogen Dynal AS, Oslo, Norway) were coated with mouse
anti-CD45 MAB (1:100; Serotec, Oxford, UK) according to the
manufacturer’s instructions. The coated beads were stored in
PBS/0.1% BSA at 4uC until use. Isolated cell suspensions were
incubated with coated beads for 1 h at 4uC with rotation. Beads
with attached CD45-positive cells were removed magnetically.
The resulting CT cells were washed four times with PBS, and the
purity was estimated by cytospins stained with anti-CD45 and
anti-CK-7 antibodies. The purity of stained cells was .98%.
Purified CT cells and HTR-8/SVneo cells detached with cold
5 mM EDTA were washed twice with cold PBS2 (PBS, 2% FCS,
and 0.01% sodium azide), and were permeabilized with fixation/
permeabilization concentrate diluted in fixation/permeabilization
diluent, 1:4 (eBioscience, San Diego, CA, USA), overnight at 4uC.
Cells were washed twice in permeabilization buffer (PB), diluted in
deionized water (1:10), and incubated with rabbit anti-gal-1,
mouse anti-gal-3, goat anti-gal-8, and rabbit anti-Ki-67 antibodies
for 45 min at 4uC. Non-permeabilized cells were incubated with
the same antibodies. After incubation and subsequent washing
with PB, cells were stained with anti-rabbit IgG Alexa Fluor 555
antibody (gal-1), anti-mouse IgG Alexa Fluor 488 (gal-3) and anti-
goat Alexa Fluor 488 (gal-8). Control cells were incubated with
non-immune rabbit IgG, non-immune mouse IgG and non-
immune goat IgG as the primary antibodies. Labeled cells were
fixed with 4% formalin, and were analyzed on an EPICS XL-
MCL flow cytometer (Coulter, Krefeld, Germany).
Statistical analysis
The data were analyzed with the Statistical Software Program,
version 5.0 (Primer of Biostatistic, McGraw-Hill Companies, Inc.,
New York, NY, USA) using the one-way analysis of variance
(ANOVA). Values were considered significantly different when
P,0.05.
Results
Expression of gal-1 in human placenta has been established
previously [16,17]. Among other placental cell types, the presence
of gal-1 has been documented for extravillous cytotrophoblast
[18,19], and also for some trophoblast derived cell lines [18,36].
This study aimed at investigating the possibility that gal-1
participates in processes relevant for human trophoblast invasion,
using anti-gal-1 with demonstrated function-blocking activity.
Therefore, our preliminary task was to establish binding of this
particular anti-gal-1 in placental tissue, fixed cells and during cell
culture. The anti-gal-1 was found to bind to gal-1 in placental
tissue (Fig. 1A) and both trophoblast cell types used in this study,
HTR-8/SVneo (Fig. 1C, E) and isolated cytotrophoblast in
primary culture (Fig. 1B). The identity of cell column trophoblast
and isolated cytotrophoblast was confirmed by anti-cytokeratin-7
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cell columns (CC) and both cell types gal-1 was localized within
cells, often perinuclearly (arrows in Fig. 1B and C), as well as in the
cell membrane domain or extracellularly (arrowheads Fig. 1B and
C). The functional tests employed here were based on the use of an
anti-gal-1 with previously demonstrated function-blocking activity
[47]. Binding of this antibody to the cell membrane of the HTR-
8/SVneo cells in culture is shown (arrowheads in Fig. 1E), which
was not the case with non-immune rabbit IgG (Fig. 1F). This
finding confirmed that this antibody specifically recognized
extravillous trophoblast gal-1 and bound to cultured cells, making
it suitable for further use in the functional studies shown below.
Cell adhesion of HTR-8/SVneo cells is influenced by lectin
type interactions and availability of gal-1
Adhesion of HTR-8/SVneo cells pretreated with non-immune
IgG or function-blocking antibody (1 or 5 mg/ml) was studied at
two time points 1 h (Fig. 2A, C) and 2 h (Fig. 2B, D), using plastic
or ECM protein coated surfaces. In order to assess participation of
lectin-type interactions in HTR-8/SVneo cell adhesion to these
surfaces, cells were also pretreated and incubated in the absence
(control) or presence of 0.1 M lactose (Fig. 2E, F). When the cells
were cultured on plastic or surfaces coated with collagen type I,
fibronectin, or Matrigel, no difference in cell adhesion was
observed with the anti-gal-1 antibody at 1 mg/ml compared to the
control after either time interval. With an anti-gal-1 concentration
of 5 mg/ml, however, after 1 h there was a small increase in
adhesion on collagen type I (115%, P,0.01). After 2 h of culture
under the same conditions adhesion to all surfaces was increased:
to 122% (P,0.05) on plastic, to 130% on collagen I (P,0.01), to
127% on fibronectin (P,0.01) and to 123% on Matrigel (not
significant). Dependance on anti-gal-1 concentration suggested
involvement of gal-1 in adhesion, possibly through its lectin
activity, which was further tested in experiments with 0.1 M
lactose, as an inhibiting sugar for galectins. Cells were either
pretreated with 0.1 M lactose or kept in control medium for 1 h
before plating on different ECM coated surfaces and were further
cultured under the same conditions for 1 or 2 h. After 1 h of
culture there was no difference compared to the control on any of
the studied surfaces (Fig. 2E), but after 2 h of incubation the
presence of 0.1 M lactose significantly reduced adhesion to plastic
to 72% of the control (P,0.001), and to a lesser degree to collagen
I (87% of the control, P,0.05). This finding suggests that lectin-
type interactions may contribute to cell adhesion of HTR-8/
SVneo cells, but the nature of the interactions remained obscure at
this point.
Galectin-1 and HTR-8/SVneo cell survival
Invasive extravillous trophoblast does not proliferate in vivo.
Nevertheless, since several members of the galectin family were
shown to affect cell proliferation in other models [48–50], this
possibility was tested for gal-1 on HTR-8/SVneo cells using the
MTT test of cell viability (Fig. 3). Two molecular forms of
recombinant human gal-1 [47,51] were used: stabilized gal-1
mutant (CS-gal-1, Fig. 3A left) with lectin activity (of gal-1) and
oxidized gal-1 (Ox-gal-1, Fig. 3A right) without lectin activity
[52]. The data obtained after 24 h indicated that both molecular
forms at all concentrations studied increased (P,0.001) absor-
bance, compared to the control. CS-gal-1 (Fig. 3A left) induced
maximal stimulation of 132% of the control value with 1 ng/ml,
which was not further increased at higher concentrations (0.1 mg/
ml and 1 mg/ml). The effect of Ox-gal-1 (Fig. 3A right) was dose
dependent (1 ng/ml, 0.1 and 1 mg/ml), with maximal stimulation
of 127% at 1 mg/ml. Also, when the MTT assay was performed
with anti-gal-1 function-blocking antibody (1 and 5 mg/ml) no
effect on HTR-8/SVneo cell viability was obtained (data not
shown). Further investigation, however, demonstrated no change
in HTR-8/SVneo cell proliferation (Fig. 3B) or apoptosis
(Fig. 3C). Percent of proliferating cells was not altered in any
culture treated with either CS-gal-1 or Ox-gal-1, compared to the
control of 55–60% positive cells. Similarly, the same treatments
did not induce any change in apoptotic cells, being 27–32% of
total cells.
Endogenous as well as added recombinant gal-1
promote trophoblast cell invasion
The focus of this study was to establish whether gal-1 is relevant
for the process of trophoblast invasion. This was approached using
a Matrigel invasion assay with isolated cytotrophoblast from first
trimester of pregnancy placenta or HTR-8/SVneo cells, in which
endogenous gal-1 was targeted by function-blocking anti-gal-1.
The results obtained for primary cytotrophoblast (Fig. 4) showed
that the presence of anti-gal-1 (5 mg/ml) decreased invasion to
75% of the control (P,0.001), where non-immune IgG was
present (Fig. 4A). Therefore, endogenous gal-1 was proposed to
participate in trophoblast cell invasion. Another set of experiments
was conducted with a cytotrophoblast Matrigel invasion system in
which the inhibiting sugar, lactose (0.1 M), was present (Fig. 4B).
Our previous data revealed that HTR-8/SVneo cell invasion was
reduced in the presence of lactose [34], which was confirmed here
for isolated cytotrophoblast with the observed inhibition to 78% of
the control value (P,0.001). Taken together, the data suggest that
lectin-type interactions of endogenous galectins, and gal-1 in
particular, participate in trophoblast cell invasion. Whether
increased availability of functional gal-1 positively correlated with
cell invasion in vitro was tested further by adding either the CS-gal-
1 or Ox-gal-1 form of recombinant human gal-1 to the invasion
test system (Fig. 4C, D). In the presence of as little as 1 ng/ml of
CS-gal-1 Matrigel invasion by cytotrophoblast was increased to
151% of the control (P,0.01), but was only slighly increased
further with 1 mg/ml (161% of control, P,0.05). However, Ox-
gal-1, which has reduced or no gal-1 lectin activity under the
conditions used, did not change cytotrophoblast cell invasion at
1 ng/ml, but induced stimulation to 192% with 1 mg/ml
(P,0.05). A similar set of tests was conducted on HTR-8/SVneo
cells (Fig. 5). Function-blocking anti-gal-1 reduced cell invasion to
66% of the control (P,0.001) with 1 mg/ml, while an increased
concentration of 5 mg/ml, did not decrease invasion further (64%
of the control incubated with non-immune IgG at the same
concentration; Fig. 5A). Thus, blocking endogenous gal-1 was
effectively induced by 1 mg/ml antibody and the effects were
comparable on the two studied trophoblast cell types. Addition of
mutant CS-gal-1 or recombinant Ox-gal-1 (Fig. 5B) on the other
hand, stimulated HTR-8/SVneo cell invasion to 317% of the
control for CS-gal-1 (1 mg/ml, P,0.001), and 200% for Ox-gal-1
(1 mg/ml, P,0.001). When lactose (0.1 M) was added to the
system, stimulation of invasion with either molecular form of gal-1
was completely abolished (Fig. 5C).
Gal-1, gal-3 and gal-8 comprise galectin profile of the
invasive trophoblast
In order to comprehend fully the relevance of these results we
wished to establish the galectin profile of the invasive cytotropho-
blast. To that end RT-PCR was conducted using published primer
sequences for human galectins 1–4, 7–10, 12–14 [45] on isolated
cytotrophoblast (Fig. 6A) and the HTR-8/SVneo cell line (Fig. 6C).
Both trophoblast cell types expressed RNAs for gal-1, gal-3 and
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cytotrophoblast only. The finding of gal-13 was established (by
subfractioning the trophoblast containing Percol layer) to result
from occasional contamination of cell preparations with fragments
of placental syncytiotrophoblast (data not shown). In order to
evaluate relative abundances of transcripts for each of the three
galectins found consistently in both cell types, real-time PCR was
conducted and the RNA levels were normalized to GAPDH RNA
(Fig. 6B, D, E). In isolated cytotrophoblast high levels of gal-3 and
gal-8 RNAs were detected compared to gal-1 (Fig. 6B), while the
opposite was the case for HTR-8/SVneo (Fig. 6D) where gal-1
RNA was the most abundantly expressed galectin RNA.
Expression at the protein level by either cell type was examined
and confirmed by Western blot of whole cell lysates (Fig. 6F). The
Figure 1. Anti-gal-1 (used throughout the study to block trophoblast cell function in vitro) localized gal-1 (A left) to extravillous CT
of the trophoblast cell column in tissue sections (CC), isolated cytotrophoblast in primary culture (B left), HTR-8/SVneo extravillous
cell line (C), and bound to HTR-8/SVneo cells in culture (E). Trophoblast identity of isolated trophoblast cells (B right) and cell column (A right)
was confirmed by staining for CK-7. The negative control for immunocytochemistry is shown in D. Gal-1 is present within cells (arrows in B, C) and
associated with the cell membrane (arrowheads in A, B, C, E; BM is basement membrane in A). For gal-1 function-blocking experiments HTR-8/SVneo
cells were cultured with either anti-gal-1 or non-immune rabbit IgG for 24 h. Binding was detected in fixed monolayers by secondary antibody (as
detailed in Material and Methods), and shown in E as membrane staining for gal-1 (arrow heads) and in F for non-specific binding (NSB). Cells were
counterstained with DAPI to visualize the nuclei (blue).
doi:10.1371/journal.pone.0028514.g001
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galectin with differences in band intensities between the cell types.
In both cell types the molecular mass of gal-1 was 14 kDa, of gal-3
it was 30 kDa, while gal-8 was detectable at 36 kDa. Based on
data from other systems, each of the expressed galectins has been
proposed to have both intracellular and extracellular functions,
which in some cases are shared between them. In order to
determine whether localization of the galectins expressed was
compatible with their participation in cell invasion, FACS analysis
of gal-1, gal-3 and gal-8 was performed on permeabilized and non-
permeabilizied cytotrophoblast (Fig. 7) and HTR-8/SVneo cells
(Fig. 8). Isolated cytotrophoblast cells were released from placental
tissue by sequential trypsin digestion, purified on a Percol gradient,
and analyzed upon purification to deplete CD45 positive cells, also
known to express galectins (as described in Material and Methods).
Staining for galectins of unpermeabilized cells (A, C, E) was
indicative of extracellular localization, while positivity in permea-
bilized cells (B, D, F) showed their presence in the cytoplasm. The
results obtained show that all three galectins are present in the
cytoplasm of isolated cytotrophoblast, as expected from the
Western blot results. The relative distribution for each galectin
differed, with gal-1 present in 74% of cells (Fig. 7B), gal-3 in 45%
(Fig. 7D) and gal-8 in 34% (Fig. 7F). However, the data regarding
the presence of these galectins at the cytotrophoblast cell
membrane were somewhat surprising, since the only galectin
found extracellularly was gal-1 in 32% of cells (Fig. 7A). Virtually
no gal-3 was present, as only 0.1% of cells were stained (Fig. 7C),
while 2.6% stained for gal-8 (Fig. 7E). Nevertheless, this result
could explain the relatively large inhibition of cytotrophoblast
invasion observed with anti-gal-1 in a cell type that expresses
Figure 2. Effect of function blocking anti-gal-1 antibodies and lactose on adhesion of HTR-8/SVneo cells to plastic, collagen type I,
fibronectin and Matrigel. Adhesion was studied after 1 h (A, C) or 2 h (B, D) using anti-gal-1 antibody (1 mg/ml in A and B; 5 mg/ml in C and D) in
adhesion to uncoated or precoated wells. The relevance of lectin-type interactions for extravillous trophoblast cell adhesion was assessed in the
presence of 0.1 M lactose after 1 h and 2 h (E, F). Data (from three experiments in triplicate) are expressed as percentages of non-immune IgG or
untreated controls, with values given as mean 6 S.E.M., and statistical significance as * for P,0.05, ** for P,0.01 and *** for P,0.001.
doi:10.1371/journal.pone.0028514.g002
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SVneo cells (Fig. 8). Intracellular localization was found for all
three galectins, gal-1 in 63% cells (Fig. 8B), gal-3 in 60% (Fig. 8D)
and gal-8 in 68% (Fig. 8F). Extracellularly, however, the only
galectin found was gal-1 in 92% cells (Fig. 8A). Extracellular gal-3
and gal-8 were detected in 0.3% and 0.1% respectively (Fig. 8C,
D).
Discussion
To the best of our knowledge this is the first study to address the
issue of the galectin profile of human invasive trophoblast cells and
the functional relevance of any galectin for trophoblast invasion.
The functional studies reported here have confirmed that gal-1
participates in trophoblast cell invasion. When endogenous gal-1
Figure 4. Availability of gal-1 influences cell invasion by isolated cytotrophoblast. The freshly isolated primary cytotrophoblast cells were
incubated during invasion with 5 mg/ml of non-immune rabbit IgG or function-blocking anti-gal-1 antibody (A), 0.1 M lactose (B), 1 ng/ml and 1 mg/
ml CS-gal-1 (C) and 1 ng/ml and 1 mg/ml Ox-gal-1 (D). Cells on the underside of the filters and the occupied pores were counted after 24 h of culture.
The data are expressed as the percentage of pores occupied in the treatment compared to the control, with values given as mean 6 S.E.M. Cell
invasion by isolated trophoblast was reduced in the presence of function-blocking anti-gal-1 (A, P,0.001), or by lactose (B, P,0.001) as an inhibiting
sugar. Treatment with CS-gal-1, 1 ng/ml and 1 mg/ml, induced stimulation of trophoblast invasion (C), P,0.01 and P,0.05 respectively, but to a lesser
degree with Ox-gal-1 (D, only with 1 mg/ml, P,0.05). Squares above the bars represent typical fields of the invasion insert. Data from at least four
individual placentas per treatment, treatments in duplicate or triplicate, entire inserts were counted.
doi:10.1371/journal.pone.0028514.g004
Figure 3. Gal-1 influence on HTR-8/SVneo cell survival. The effect of mutant gal-1, CS-gal-1 (A left) and oxidized gal-1, Ox-gal-1 (A right) on
HTR-8/SVneo cell viability. Cells were maintained for 24 h in RPMI 1640 medium with 0.1% BSA without (control) or with CS-gal-1 or Ox-gal-1 (1, 100
and 1000 ng/ml). Values are given as percentages of control values (mean 6 S.E.M.), three experiments, six replicates each. Differences vs control
significant at P,0.001 (***). Effect of the same gal-1 forms (1 ng/ml and 1 mg/ml) on proliferation (B), evidenced as percent of Ki-67 positive cells, and
apoptosis (C), evidenced by PI staining (FACS analysis).
doi:10.1371/journal.pone.0028514.g003
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while additional recombinant gal-1 stimulated cell invasion. The
data presented confirm expression of the three galectins, gal-1, gal-
3 and gal-8, and provide cellular localization for each, which has
not been reported so far for human invasive trophoblast cells.
Interactions of glycoconjugates with endogenous lectins such as
galectins, have been long proposed to participate in several
reproductive processes including fertilization, blastocyst attach-
ment, and implantation [53]. Previous seminal studies that
addressed the physiological significance of galectins for repro-
duction were conducted in mice with gene neutralization of gal-1
alone [25], or with gal-3 [27]. A long standing interest of this
group has been the relevance of galectins for the invasive
properties of normal and transformed trophoblast. Gal-1, gal-3,
and gal-8 are expressed by the invasive extravillous trophoblast of
the cell column [18,19,23] and the immortalized invasive
trophoblast cell line HTR-8/SVneo [36]. Therefore, in the
present investigation the issue of potential participation of gal-1 in
human trophoblast cell invasion in vitro using cell models was
examined. This approach was based on the availability of a
unique anti-gal-1 antibody with function blocking characteristics
demonstrated in other systems [47], as well as two molecular
forms of biologically active recombinant human gal-1 [51]. In
neurobiology, application of the same anti-gal-1 antibody with
neutralizing activity strongly inhibited axonal regeneration of
peripheral nerves after axotomy, both in vivo and in vitro [47]. In
order to use this antibody to block cell function of the
trophoblast, it was initially tested for recognition of gal-1 at the
previously described placental locations. It was found to
recognize gal-1 at all sites and cell types as previously described,
and also to bind to HTR-8/SVneo cells in culture. Therefore, it
was concluded that the anti-gal-1 used here met the initial criteria
for further use to block cell functions.
Cell adhesion in general depends on the presence of membrane
constituents able to bind stably to different surfaces. Since we have
previously demonstrated that lactose, an inhibitory sugar for the
lectin-type interaction of galectins, reduced invasion by the
extravillous trophoblast HTR-8/SVneo cell line [36], its possible
effect on cell adhesion was examined here. We hypothesized that
endogenous gal-1 could participate in cell adhesion by binding cell
membrane glycoproteins and/or ECM proteins produced by cells
or present in the culture vessel coating. This was confirmed by our
finding that lactose inhibited HTR-8/SVneo cell adhesion to
plastic and collagen type I. Antibody that binds this gal-1 could in
turn interfere with the efficiency of cell adhesion. In the presence
of anti-gal-1 antibody, cell adhesion was increased to both plastic
and ECM protein coated surfaces. This was an intriguing finding
which probably reflects complex interactions between endogenous
gal-1, its trophoblast ligands, and the antibody introduced into the
test system. There is a possibility that the antibody reinforces
existing complexes and adhesion, and/or further cross links
membrane and ECM bound gal-1. A similar effect of the function
blocking antibody could result from elimination of potential steric
hinderance induced by gal-1, which, however, was not studied
Figure 5. Availability of gal-1 influences HTR-8/SVneo cell
invasion. Cells were incubated with 1 and 5 mg/ml of non-immune IgG
or anti-gal-1 antibodies (A), 1 mg/ml of CS-gal-1 or Ox-gal-1 alone (B) or
in combination with 0.1 M lactose (C). Cells on the underside of the
filters and the occupied pores were counted after 24 h of culture. The
data are expressed as the percentage of pores occupied in the
treatment compared to the control value, with data given as mean 6
S.E.M. For treatments with CS-gal-1 and Ox-gal-1 data were normalized
to take into account the increase in cell number.The presence of
function-blocking anti-gal-1 (A, at 1 and 5 mg/ml) significantly reduced
invasion with no difference between the two concentrations (P,0.001,
four experiments, in duplicate for 1 mg/ml; P,0.001, eight experiments
in duplicate for 5 mg/ml of anti-gal-1 IgG). The addition of gal-1
significantly stimulated cell invasion, which was considerably lower for
Ox-gal-1 than for CS-gal-1 at 1 mg/ml (B, P,0.001 for CS-gal-1, P,0.001
for Ox-gal-1; three experiments in duplicate for each molecular form of
gal-1). This stimulatory activity was abolished in the presence of 0.1 M
lactose for both forms of recombinant gal-1 (C). Squares above the bars
represent typical fields of the invasion insert.
doi:10.1371/journal.pone.0028514.g005
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increased attachment to laminin in a dose-dependent manner,
which could be abolished by lactose [54] and anti-gal-1. In a
smooth muscle cell model chemical cross-linking of gal-1 to b1
integrin indicated that dimeric gal-1 bound to a single molecule of
b1 integrin and did not cross-link two b1 integrin molecules [11].
Nevertheless, this binding increased the availability of b1 integrin
subunits on the cell surface and their activation. By analogy,
endogenous cell surface gal-1 of HTR-8/SVneo cells could be
bound to b1 integrin and potential further linking of gal-1 ligated
membrane and ECM glycoproteins could be achieved by the
antibody, possibly activating additional adhesive mechanisms.
Gal-1 does not have specific receptors, but possible ligands or
counter-receptors include ECM glycoproteins, as well as mem-
brane glycoproteins, such as integrins. Cell column trophoblast
cells in vivo [55,56] and HTR-8/SVneo cells (our data, not shown)
produce ECM proteins including laminin and oncofetal fibronec-
tin. The invasive cytotrophoblast and HTR-8/SVneo cells also
express the integrin receptors for these ECM proteins [55,57,58].
Both classes of glycoproteins are heavily glycosylated and
identified as ligands for gal-1 in several systems and placenta
[13]. Therefore, participation of gal-1 in cell adhesion and
Figure 6. Galectin expression profile of freshly isolated trophoblast and extravillous cell line HTR-8/SVneo. RT-PCR analysis
demonstrates the presence of transcripts for gal-1, gal-3 and gal-8 in both isolated cytotrophoblast (A) and HTR-8/SVneo cell line (C) and gal-13 from
contaminating ST in the CT cell preparation. The sizes of standard (DNA) fragments are indicated by arrow heads. Relative levels of gal-1, -3 and -8
were determined by real-time PCR in both cell types (B for isolated CT, D for HTR-8/SVneo; internal control GAPDH). Comparison between the two cell
types (E) isolated CT (x-axis) and extravillous cell line HTR-8/SVneo (y-axis). Western blot analysis of gal-1, gal-3 and gal-8 proteins in whole cell lysates
of freshly isolated cytotrophoblast and HTR-8/SVneo cells (F), resolved by SDS-PAGE on 15% gel under reducing conditions. Densitometric analysis by
ImageMaster TotalLab v2.01 programme. Protein bands of appropriate molecular mass are indicated with arrow heads; b-actin served as the loading
control. A representative experiment of three for each cell type is shown for RT-PCR, real-time PCR and immunoblot.
doi:10.1371/journal.pone.0028514.g006
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PLoS ONE | www.plosone.org 11 December 2011 | Volume 6 | Issue 12 | e28514Figure 7. Cytofluorometrical analysis of the expressed galectin proteins in isolated CT. The x-axis indicates fluorescence intensity measured
on a log10 scale, and the y-axis indicates event counts on a linear scale. Specific staining is shown as gray, and non-specific staining (isotype-matched control
IgG) as white histograms. Either non-permeabilized (A, C, E), or permeabilized cells (B, D, F) were probed for expression of gal-1 (A, B), gal-3 (C, D) and gal-8 (E, F)
using appropriate antibodies. The percentages of non-permeabilized and permeabilized gal-1, -3 and -8 positive cells are shown in each histogram. A
representative experiment of three is shown.
doi:10.1371/journal.pone.0028514.g007
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PLoS ONE | www.plosone.org 12 December 2011 | Volume 6 | Issue 12 | e28514Figure 8. Cytofluorometrical analysis of the expressed galectin proteins in HTR-8/SVneo cells. The x-axis indicates fluorescence intensity
measured on a log10 scale, and the y-axis indicates event counts on a linear scale. Specific staining is shown as gray, and non-specific staining
(isotype-matched control IgG) as white histograms. Either non-permeabilized (A, C, E), or permeabilized cells (B, D, F) were probed for expression of
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structures as has been described for gal-1 on T cells, and other
members of the galectin family, such as gal-3 [59].
It has been found that gal-1 modulates proliferation of different
types of cells. The effects of gal-1 on cell proliferation are
multifaceted and can be positive or negative, depending on the cell
line and/or subcellular localization. The data presented here show
increased absorbance in MTT test, suggesting stimulation of cell
proliferation in HTR-8/SVneo cells, induced by exogenous
recombinant gal-1. This, however, was not accompanied with
change in abundance of proliferating or apoptotic cells. In some
other responsive cell types gal-1 effects have been dissociated from
proliferation and alterations in cell cycle. It has been shown in T
cells that gal-1 can support cell survival without promotion of cell
proliferation [60]. However, gal-1 isolated from placental tissue
inhibited proliferation of choriocarcinoma cell line BeWo cells and
reduced cellular uptake of BrdU at concentrations as high as
30 mg/ml and 60 mg/ml [61]. In BeWo cells the signaling cascade
of gal-1 at high concentrations is proposed to include receptor
tyrosine kinases JAK2, RET and VEGFR3 [62]. Apparently, the
gal-1 growth promoting effect is cell-type specific, concentration
sensitive, and could be both carbohydrate-dependent or -
independent.
Availability of gal-1 is shown here for the first time to be
important for trophoblast invasion in vitro. Since blocking
endogenous gal-1, as well as supplementation with recombinant
gal-1, is directly correlated with cell invasion, we propose that gal-
1 functions as an important constituent of the molecular profile of
invasion competent human trophoblast. The stabilized form of
gal-1 (CS-gal-1) was more potent in inducing invasion, as a 1000
times higher concentration of Ox-gal-1 was required for a
significant increase, indicating the relevance of lectin type
interactions in this process. A molecular form dependent effect
of gal-1 was described in an axonal regeneration model [51]. Our
finding of gal-1 stimulation of human trophoblast could seem
contradictory to the reported mouse knock-down data, but
increasing data in the literature suggest that species-specific
glycotypes exist [63], which could consequently be reflected by
species specific relevance of their binding proteins, such as
galectins. On the other hand, gal-1 is increasingly associated with
invasiveness of cancer cells. Increased expression of gal-1 in
hepatocellular carcinoma is significantly linked to the presence of
metastasis [64]. We have previously shown that gal-1 is
overexpressed in trophoblast of choriocarcinoma, invasive mole
and placental site trophoblastic tumor [35]. Knocking down gal-1
with small interfering RNA in highly invasive cancer cells reduced
invasion [38,65]. Overexpression of gal-1 in an oral carcinoma cell
model resulted in an increase of cell migration and invasion in low
metastatic cancer cells in vivo and in vitro implicating matrix
metalloproteinase (MMP-2 and MMP-9) expression [38], which
however was not shown for HTR-8/SVneo cells (our unpublished
observation). The finding that gal-1 is regulated by hypoxia in
colorectal cells [66] is of potential significance for trophoblast. In
early pregnancy physiological trophoblast invasion is achieved in
hypoxic conditions, and sensitivity of trophoblast functions to HIF
has been documented [67]. Gal-1-induced migration and invasion
in hepatoma HuH-7 cells were mediated by the stimulation of Syk
phosphorylation [66]. However, pathways and the effector
molecules involved in gal-1 stimulation of normal human
trophoblast invasiveness remain to be established. In general,
exchange of receptors between membrane domains is a critical
aspect of cellular sensitivity to extracellular cues. For EGFR and
other cytokine receptors (including TGFbR, PDGFR, and IGFR),
receptor recruitment to the galectin lattice potentiates ligand
induced clustering and signaling [68]. There is a possibility that
the same holds true for trophoblast and yet unidentified growth
factor/cytokine receptors, so that altered/reduced accessibility of
these receptors caused by anti-gal-1 antibody would consequently
decrease signaling by serum or autocrine factors, for instance in
cell invasion, as shown here. Conversely, increased availability of
soluble gal-1 could result in its binding to additional membrane
and/or ECM ligands and further crosslinking leading to increased
invasion.
Since binding characteristics are shared among the members of
the galectin family and their cellular functions may overlap, we
undertook to determine the galectin localization in isolated
trophoblast of first trimester of pregnancy and the established
trophoblast cell line HTR-8/SVneo. Among the 11 galectins
tested, galectins 1,-3, and -8 were consistently present in both
trophoblast cell types, at mRNA and protein levels. However, their
cellular distribution strikingly identified gal-1 as the only one with
extracellular localization, which could possibly explain the
considerable influence of antibodies to gal-1 on trophoblast
invasion. The finding that the profile obtained is the same for
cells of the established cell line detached without trypsin and
trophoblast cells isolated from tissue using trypsin reduces the
possibility that the absence of extracellular gal-3 and gal-8 was
induced by the procedure used. Multiple galectins are also present
in other tissues such as endometrium and decidua, endothelium,
ovary cells, etc [20,45,69]. The same three galectins are expressed
in human embryonic kidney HEK-293 and human foreskin
fibrobasts [70]. The influence of galectin binding to membrane
proteins and integrins in particular has been well studied and
documented for gal-1, gal-3 and gal-8. In multiple cell lines gal-8
binding to different integrins inhibited cell adhesion [71], but the
effect was not shared by gal-1 or gal-3 in the same cell types.
Obviously, there is a need for further investigation of specific
functions of each of the galectins expressed by the invasive
trophoblast.
The dynamics and nature of binding partners for gal-1
responsible for the effect on trophoblast cell invasion remain to
be elucidated in the future. A very complex picture is likely to
emerge, given the expression of multiple galectins and gal-1 in
particular by distinct, yet often adjacent cell types present within
the placental bed.
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